First-rate service

We provide first-rate service on the BPS-Pharmacotherapy learning prep to the clients and they include the service before and after the sale, 24-hours online customer service and long-distance assistance, the refund service and the update service. The client can try out our and download BPS-Pharmacotherapy guide materials freely before the sale and if the client have problems about our product after the sale they can contact our customer service at any time. We provide 24-hours online customer service which replies the client's questions and doubts about our BPS-Pharmacotherapy training quiz and solve their problems. Our professional IT personnel provide long-distance assistance online. If the clients can't pass the exam we will refund them immediately in full at one time. Our expert team will check the update BPS-Pharmacotherapy learning prep and will send the update version automatically to the clients if there is the update. We provide free update within one year. So the clients can enjoy the convenience of our wonderful service and the benefits brought by our superior BPS-Pharmacotherapy guide materials.

Nowadays the competition in the society is fiercer and if you don't have a specialty you can't occupy an advantageous position in the competition and may be weeded out. Passing the test BPS certification can help you be competent in some area and gain the competition advantages in the labor market. If you buy our study materials you will pass the test smoothly. Our product boosts many advantages and it is your best choice to prepare for the test. Our BPS-Pharmacotherapy learning prep is compiled by our first-rate expert team and linked closely with the real exam. Our study materials provide 3 versions and multiple functions to make the learners have no learning obstacles. The passing rate of our BPS-Pharmacotherapy guide materials is high and you don't need to worry that you have spent money but can't pass the test. We can't list all the advantages with several words and please read the introduction of the features and advantages of our BPS-Pharmacotherapy training quiz in detail as follow.

DOWNLOAD DEMO

Multiple functions to help the client learn efficiently

Our product boosts multiple functions and they can help the clients better learn our study materials and prepare for the test. Our BPS-Pharmacotherapy learning prep boosts the self-learning, self-evaluation, statistics report, timing and test stimulation functions and each function plays their own roles to help the clients learn comprehensively. The self-learning and self-evaluation functions of our BPS-Pharmacotherapy guide materials help the clients check the results of their learning of the study materials. The statistics report function helps the learners find the weak links and improve them accordingly. The timing function of our BPS-Pharmacotherapy training quiz helps the learners to adjust their speed to answer the questions and keep alert and our study materials have set the timer. The function to stimulate the exam helps the learners be adjusted to the atmosphere, pace and environment of the real BPS-Pharmacotherapy exam. So our product can help you learn the study materials and prepare for the test in many ways.

Immediate download and use after you pay successfully

The clients can download our products and use our study materials immediately after they pay successfully. Our system will send our BPS-Pharmacotherapy learning prep in the form of mails to the client in 5-10 minutes after their successful payment. The mails provide the links and if only the clients click on the links they can log in our software immediately to learn our BPS-Pharmacotherapy guide materials. The procedures are simple and save the clients' time. Because the most clients may be busy in their jobs or other significant things, the time they can spare to learn our study materials is limited and little. But if the clients buy our BPS-Pharmacotherapy training quiz they can immediately use our product and save their time.

BPS Pharmacotherapy (Part1 and Part2) Sample Questions:

1. A pharmacotherapy specialist in a managed-care organization is about to review a new drug for the treatment of osteoporosis. The P&T committee will use the results in deciding whether to add the new drug to the formulary. Which of the following information would be most helpful?

A) With the new drug, the number of patients needed to treat for the prevention of one fracture is 25.
B) The annual cost of the new drug for the organization's population of patients with osteoporosis would be $2.7 million
C) The new drug will cost $15600 more than the current formulary drug to prevent one fracture.
D) The new drug is associated with a 32% reduction in the fracture rate.

2. In a clinical trial, when would "intention to treat" analysis be most appropriate?

A) Phase || trial
B) Crossover design
C) Small sample size
D) High drop-out rate

3. What is the most appropriate source for identifying the generic name, classification, and adverse effects of a foreign brand-name medication?

A) Drug Facts & Comparisons
B) Micromedex
C) American Hospital Formulary Service Drug information
D) Martindale: The Complete Drug Reference

4. A postmenopausal patient with osteoporosis is being switched from conjugated estrogen to raloxifene treatment. Which of the following should be communicated to this patient as the best outcome that has been documented with raloxifene?

A) Decreased incidence of cardiovascular events
B) Lower likelihood of thromboembolic events
C) Decreased incidence of Vertebral fractures
D) Decreased incidence of hot flushes

5. A 72-year-old patient, weighing 72 kg and measuring 173 cm tall, presents to the emergency department with an acute ischemic stroke. The symptoms have been present for just over an hour. The patient has a history of hypertension and is currently taking lisinopril 10 mg daily.
The patient's evaluation reveals no intracerebral hemorrhaging. The current BP is 178/100 mm Hg. It is now 150 minutes from stroke symptom onset.
Which of the following should now be administered?

A) An antihypertensive; reconsider intravenous t-PA once BP decreases
B) Intravenous glycoprotein IIb/IIIa inhibitor
C) An antihypertensive; reconsider intra-arterial thrombolytics once BP decreases
D) Intravenous-PA

Solutions: